At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters.

The Position

Roche - we advance science so that we all have more time with the people we love

Our Global Pharma Strategy (GPS) team plays a pivotal role in shaping the future of healthcare by driving the strategic direction of our innovative product portfolio. As a member of the GPS team, you will be at the forefront of transforming groundbreaking scientific discoveries into accessible and impactful healthcare solutions for patients worldwide. We are seeking a dynamic and visionary professional who thrives in a collaborative environment and is passionate about making a difference.

As the Commercialization Strategy Leader for Parkinson's Disease you drive the global commercialization strategy to achieve market leadership for our products. You collaborate closely with the US, Pharma International, Product Development (PD), and various key partners in Global Pharma Strategy (GPS) to shape development decisions with commercialisation in mind as well as design integrated commercialization strategies that ensure maximum impact in our markets. You ensure alignment to a strong global ambition and drive collaboratively to achieve it.

The Opportunity:

• Lead the Commercial Leadership Team (CLT), promoting a high-performance culture with accountability for driving exceptional collaboration across the team to deliver outstanding business outcomes

• Develop comprehensive commercialization strategies and set unified outcomes that will achieve the disease areas and product ambitions. Work closely with counterparts in the CLT to collaborate on aligning these and achieving them

• Act as the key interface between the CLT and Lifecycle Teams (LCTs), ensuring alignment and effective communication of the asset development strategy into a cohesive disease area commercialisation strategy

• Supply a strong voice of the business in governance conversations and development processes (e.g., LSPC, DAS, Asset Strategies and LCT) to support robust decision-making E2E along the full value chain

• Provide strategic input and insights into early-stage assets, ensuring end-to-end alignment across functions and partners

• Guide allocation of resources and budgets to ensure the realization of high-reaching business goals.

Who You Are:

• A high level of experience in commercial and strategic leadership roles in the pharma/biotech industry. An understanding of both market realities and development processes is important

• Proven ability to lead enterprise efforts and outstanding VACC leadership skills with the shown ability to inspire and mobilise the teams towards a vision of high ambition and succeeding together- building a culture of high performance, accountability, collaboration, diversity, inclusion and trust

• A System thinker who understands and leads with an enterprise and collective mindset; someone who understands and appreciates the realities of the development process as much as the US and PI environments in order to put all these pieces together to form global strategies

• Deep sense of customer centricity and strong strategic thinking ability to drive strategy and outcomes development to achieve DA market leadership

• Acts with a sense of urgency and curiosity, takes smart risks; embodies an entrepreneurial growth mindset with the right balance between long term and short term outcomes.

Join us in our mission to advance science and deliver hope to those who need it most.

Who we are

A healthier future drives us to innovate. Together, more than 100’000 employees across the globe are dedicated to advance science, ensuring everyone has access to healthcare today and for generations to come. Our efforts result in more than 26 million people treated with our medicines and over 30 billion tests conducted using our Diagnostics products. We empower each other to explore new possibilities, foster creativity, and keep our ambitions high, so we can deliver life-changing healthcare solutions that make a global impact.

Let’s build a healthier future, together.